Parallel Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20
| Closed | -$106 | – | 3515 |
|
|
2024
Q3 | $106 | Hold |
20
| – | – | ﹤0.01% | 3318 |
|
|
2024
Q2 | $36 | Hold |
20
| – | – | ﹤0.01% | 3263 |
|
|
2024
Q1 | $36 | Hold |
20
| – | – | ﹤0.01% | 3229 |
|
|
2023
Q4 | $35 | Hold |
20
| – | – | ﹤0.01% | 3257 |
|
|
2023
Q3 | $29 | Hold |
20
| – | – | ﹤0.01% | 3306 |
|
|
2023
Q2 | $46 | Hold |
20
| – | – | ﹤0.01% | 3308 |
|
|
2023
Q1 | $18 | Hold |
20
| – | – | ﹤0.01% | 3376 |
|
|
2022
Q4 | $17 | Hold |
20
| – | – | ﹤0.01% | 3305 |
|
|
2022
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 3176 |
|
|
2022
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 3034 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 3007 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 3111 |
|
|
2021
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 3074 |
|
|
2021
Q2 | $0 | Buy |
+20
| New | – | ﹤0.01% | 2932 |
|